skip to main content
X

Absent Final Federal Rule, IRS Reaffirms that Cannabis Still Subject to Limitations of 280E

Absent Final Federal Rule, IRS Reaffirms that Cannabis Still Subject to Limitations of 280E

News from earlier this year that the Biden administration was poised to move forward with a Department of Health and Human Services recommendation to reclassify cannabis from a Schedule I drug to a Schedule III sent positive outlooks across the industry centered around the elimination of Internal Revenue Service’s code Section 280E. Section 280E prohibits legal cannabis companies from deducting what would otherwise be ordinary business expenses.

Many multi-state operators have claimed refunds on the basis that code Section 280E is no longer applicable to legal cannabis operators. The IRS recently issued a statement reminding owners of cannabis companies that without a published final federal rule reclassifying cannabis to a Schedule III drug, Section 280E still applies, even in states that have legalized cannabis.

Hold off on amended tax returns

Without an official ruling of reclassification, cannabis remains a Schedule I controlled substance and taxpayers are not entitled to refunds related to Section 280E. The IRS has been receiving amended returns with claims based on different criteria but has stated that these claims are invalid. They are taking steps to address these claims to avoid confusion and wasted resources.

Owners of cannabis companies are still eligible to reduce their gross receipts by properly calculating cost of goods sold to determine gross income.

Await further guidance from a cannabis specialist

Our dedicated cannabis accounting specialists have been assisting clients with 280E and monitoring industry trends as more states legalize cannabis for medical and recreational use. We will continue to monitor information from the IRS and other governing bodies to inform our contacts of any developments pertinent to their businesses including the publication of a final federal reclassification.

 

07/08/2024

Have a Question?

Fill out the form to speak with one of our cannabis professionals.

Hide Firm Disclaimer

©2024 UHY LLP. ALL RIGHTS RESERVED.

UHY LLP is a licensed independent CPA firm that performs attest services in an alternative practice structure with UHY Advisors, Inc., and its subsidiary entities. UHY Advisors, Inc.’s subsidiaries, including UHY Consulting, Inc., provide tax and business consulting services through wholly owned subsidiary entities that operate under the name of “UHY Advisors” and “UHY Consulting”. UHY Advisors, Inc., and its subsidiary entities are not licensed CPA firms. UHY LLP, UHY Advisors, Inc. and UHY Consulting are U.S. members of Urbach Hacker Young International Limited, a UK company, and form part of the international UHY network of legally independent accounting and consulting firms. “UHY” is the brand name for the UHY international network. Any services described herein are provided by UHY LLP, UHY Advisors and/or UHY Consulting (as the case may be) and not by UHY or any other member firm of UHY. Neither UHY nor any member of UHY has any liability for services provided by other members.

On this website, (i) the term "our firm", "we" and terms of similar import, denote the alternative practice structure conducted by UHY LLP and UHY Advisors, Inc. and its subsidiary entities, and (ii) the term "UHYI" denotes the UHY international network, in each case as more fully described in the preceding paragraph.